BackgroundMiddle meningeal artery embolization (MMAE) has revolutionized the armamentarium for chronic subdural hematoma (CSDH) treatment. Technical and angiographic benchmarks to guide procedural and clinical success are less well-established. MethodsA single-center database was reviewed to compare outcomes after standalone MMAE with and without resultant residual angiographic opacification of frontal and parietal (F/P) branches. Primary outcome was surgical rescue for CSDH progression. Secondary outcomes included the efficiency and accumulated efficacy of hematoma-resolution. Effect sizes were adjusted via multivariable regression. ResultsOf 147 standalone MMAE for CSDH, the overall rate of surgical rescue was 6.8%. Non-opacification of F/P branches via proximal MMA or meningo-ophthalmic anastomosis, was achieved after 83% of procedures and was associated with a 7-fold decreased rate of surgical rescue (3.3% vs. 24%, P=0.001). At 90-day follow-up, a higher rate of hematoma-resolution ≥ 50% was achieved if no residual opacification was identified (82% vs. 56%, P=0.03). The median time-to-50%-hematoma-resolution was 44 days for the no-residual group versus 71 days for the residual group (P<0.001). The unfavorable effects of residual opacification of F/P branches were verified in a multivariate analysis: a higher risk of surgical-rescue (adjusted OR 24.6; P=0.001) and poor hematoma resolution were both confirmed (adjusted HR 0.3; P=0.001). ConclusionMMAE with non-opacification of F/P branches was associated with augmented efficacy. Nuanced MMAE adequately tackling culprit dural feeders should be considered for more effective procedures.
Read full abstract